Form 8-K - Current report:
SEC Accession No. 0001193125-18-131571
Filing Date
2018-04-25
Accepted
2018-04-25 17:01:02
Documents
1
Period of Report
2018-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d575316d8k.htm 8-K 13394
  Complete submission text file 0001193125-18-131571.txt   14594
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 18775032
SIC: 2834 Pharmaceutical Preparations